These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28063224)

  • 1. Current Status and Prospective Regarding the Therapeutic Potential of Natural Autoantibodies in Cancer Therapy.
    Ebrahimnezhad S; Jazayeri M; Hassanian SM; Avan A
    J Cell Physiol; 2017 Oct; 232(10):2649-2652. PubMed ID: 28063224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally occurring auto-antibodies in homeostasis and disease.
    Lutz HU; Binder CJ; Kaveri S
    Trends Immunol; 2009 Jan; 30(1):43-51. PubMed ID: 19058756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Antibodies: from First-Line Defense Against Pathogens to Perpetual Immune Homeostasis.
    Maddur MS; Lacroix-Desmazes S; Dimitrov JD; Kazatchkine MD; Bayry J; Kaveri SV
    Clin Rev Allergy Immunol; 2020 Apr; 58(2):213-228. PubMed ID: 31161341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies, autoimmunity and cancer (review).
    Tomer Y; Sherer Y; Shoenfeld Y
    Oncol Rep; 1998; 5(3):753-61. PubMed ID: 9538189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers, self-antigens and the immunological homunculus.
    Cohen IR
    J Autoimmun; 2007 Dec; 29(4):246-9. PubMed ID: 17888625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of benign autoimmunity as both tumor and autoimmune disease immunotherapy: a comprehensive review.
    Cohen IR
    J Autoimmun; 2014 Nov; 54():112-7. PubMed ID: 24924121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural autoantibodies in the physiology and pathophysiology of the immune system.
    Avrameas S; Selmi C
    J Autoimmun; 2013 Mar; 41():46-9. PubMed ID: 23384670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunization to epidermal growth factor, a component of the immunological homunculus.
    Gonzalez G; Montero E; Leon K; Cohen IR; Lage A
    Autoimmun Rev; 2002 Feb; 1(1-2):89-95. PubMed ID: 12849064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinuclear autoantibodies as potential antineoplastic agents.
    Torchilin VP; Iakoubov LZ; Estrov Z
    Trends Immunol; 2001 Aug; 22(8):424-7. PubMed ID: 11473830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homeostatic roles of naturally occurring antibodies: an overview.
    Lutz HU
    J Autoimmun; 2007 Dec; 29(4):287-94. PubMed ID: 17826952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immuno-oncology--silver bullets or mass destruction weapons?].
    Utriainen M; Rämet M
    Duodecim; 2016; 132(8):721-8. PubMed ID: 27244931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PD-1/PD-L1 pathway: biological background and clinical relevance of an emerging treatment target in immunotherapy.
    Muenst S; Soysal SD; Tzankov A; Hoeller S
    Expert Opin Ther Targets; 2015 Feb; 19(2):201-11. PubMed ID: 25491730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural autoantibodies and associated B cells in immunity and autoimmunity.
    Mannoor K; Xu Y; Chen C
    Autoimmunity; 2013 Mar; 46(2):138-47. PubMed ID: 23186367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles and applications of autoantibodies in progression, diagnosis, treatment and prognosis of human malignant tumours.
    Wu J; Li X; Song W; Fang Y; Yu L; Liu S; Churilov LP; Zhang F
    Autoimmun Rev; 2017 Dec; 16(12):1270-1281. PubMed ID: 29042252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments and future challenges in immune checkpoint inhibitory cancer treatment.
    Koster BD; de Gruijl TD; van den Eertwegh AJ
    Curr Opin Oncol; 2015 Nov; 27(6):482-8. PubMed ID: 26352539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiological autoimmunity].
    Ternynck T; Druet P; Avrameas S
    Rev Prat; 1994 Jan; 44(1):36-8. PubMed ID: 8178056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy.
    Lu J; Lee-Gabel L; Nadeau MC; Ferencz TM; Soefje SA
    J Oncol Pharm Pract; 2015 Dec; 21(6):451-67. PubMed ID: 24917416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-faceted role of naturally occurring autoantibodies in fighting pathogens.
    Bouhlal H; Kaveri S
    Adv Exp Med Biol; 2012; 750():100-13. PubMed ID: 22903669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The humoral immune response in autoimmunity.
    Calvanico NJ
    Dermatol Clin; 1993 Jul; 11(3):379-89. PubMed ID: 8365026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.